Moreover, RT-qPCR confirmed that SEMA5B expression was significantly elevated in ccRCC, and SEMA5B was identified as a target gene of HIF that promoted tumor growth in vivo (Kundu et al., 2020). The gene discussed is SEMA5B; the disease is neoplasm.